Glaucoma study: Biofeedback Training
Official title Efficacy of Biofeedback Training for Glaucoma
ClinicalTrials.gov ID: NCT07409077
What this study is testing
- What it's testing
- The study wants to see whether training patients to move their eyes toward clearer parts of the retina can improve their vision and how they feel about their sight.
- Who it's for
- Adults who have been diagnosed with glaucoma and can participate in eye‑movement training.
- What's involved
- Participants will be randomly assigned to either receive the biofeedback training or a control condition. They will have eye‑movement tests and vision checks at the start and during follow‑up visits.
- Time commitment
- The trial lasts about a few months, with several scheduled visits for testing and training sessions.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- 18-95 years old.
- Glaucoma cases with adequate intraocular pressure control.
- Presence of paracentral scotomata within two degrees of fixation.
- Ability to follow instructions for biofeedback training.
You likely can't join if
- Prior or current low vision rehabilitation treatment.
- Ocular diseases or severe clinical conditions unrelated to glaucoma
- Media opacities that prevent reliable microperimetry testing in both eyes.
- Inability to perform study assessments or follow instructions for biofeedback training.
The study team makes the final eligibility decision.
Where it is enrolling
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.